Bruce Rogers - Sep 9, 2021 Form 4 Insider Report for Morphic Holding, Inc. (MORF)

Role
Chief Scientific Officer
Signature
/s/ Robert Farrell as attorney-in-fact for Bruce Rogers
Stock symbol
MORF
Transactions as of
Sep 9, 2021
Transactions value $
-$2,307,245
Form type
4
Date filed
9/13/2021, 07:04 PM
Next filing
Oct 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MORF Common Stock Options Exercise $130K +30K +33.37% $4.32* 120K Sep 9, 2021 Direct F1
transaction MORF Common Stock Sale -$102K -1.7K -1.42% $59.99 118K Sep 9, 2021 Direct F2, F3
transaction MORF Common Stock Sale -$1.35M -22.2K -18.79% $60.87 96K Sep 9, 2021 Direct F2, F4
transaction MORF Common Stock Sale -$375K -6.09K -6.34% $61.60 89.9K Sep 9, 2021 Direct F2, F5
transaction MORF Common Stock Options Exercise $35.8K +8.28K +9.21% $4.32* 98.2K Sep 10, 2021 Direct
transaction MORF Common Stock Sale -$539K -8.28K -8.43% $65.11 89.9K Sep 10, 2021 Direct F2, F6
transaction MORF Common Stock Options Exercise $7.43K +1.72K +1.91% $4.32* 91.6K Sep 13, 2021 Direct
transaction MORF Common Stock Sale -$112K -1.72K -1.88% $65.00 89.9K Sep 13, 2021 Direct F2, F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MORF Stock Option (right to buy Common Stock) Options Exercise $0 -30K -13.59% $0.00 191K Sep 9, 2021 Common Stock 30K $4.32 Direct F8
transaction MORF Stock Option (right to buy Common Stock) Options Exercise $0 -8.28K -4.34% $0.00 182K Sep 10, 2021 Common Stock 8.28K $4.32 Direct F8
transaction MORF Stock Option (right to buy Common Stock) Options Exercise $0 -1.72K -0.94% $0.00 181K Sep 13, 2021 Common Stock 1.72K $4.32 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 56 shares of Common Stock acquired under the issuer's employee stock purchase plan on August 31, 2021.
F2 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.42 to $60.36 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.42 to $61.41 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.42 to $61.82 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.53 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.12 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8 The option vests as to 2.0833% of the total shares monthly, beginning January 14, 2019, with 100% of the total shares vested and exercisable on December 14, 2022, subject to the reporting person's provision of service to the issuer on each vesting date.